Watershed Private Wealth’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,843
Closed -$219K 116
2024
Q3
$219K Hold
1,843
0.09% 109
2024
Q2
$263K Hold
1,843
0.11% 96
2024
Q1
$237K Buy
+1,843
New +$219K 0.1% 108

Other funds holding NVO

Watershed Private Wealth's NVO Position: Q4 2024 in Review

Watershed Private Wealth sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,843 shares — an estimated $219K sold.

Watershed Private Wealth first reported a position in NVO in Q1 2024 and held it in 3 quarters. The position peaked at $263K in Q2 2024. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Watershed Private Wealth reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Watershed Private Wealth sold 1,843 Novo Nordisk shares in Q4 2024, an estimated $219K.
  • Watershed Private Wealth first reported a position in Novo Nordisk in Q1 2024 and held it in 3 quarters.
  • Watershed Private Wealth's Novo Nordisk position peaked at $263K in Q2 2024.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Watershed Private Wealth's 13F filing for Q4 2024, filed 22 Jan 2025.